Unknown

Dataset Information

0

TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.


ABSTRACT: SARS-CoV-2, the coronavirus that causes the disease COVID-19, has claimed millions of lives over the past 2 years. This demands rapid development of effective therapeutic agents that target various phases of the viral replication cycle. The interaction between host transmembrane serine protease 2 (TMPRSS2) and viral SPIKE protein is an important initial step in SARS-CoV-2 infection, offering an opportunity for therapeutic development of viral entry inhibitors. Here, we report the development of a time-resolved fluorescence/Förster resonance energy transfer (TR-FRET) assay for monitoring the TMPRSS2-SPIKE interaction in lysate from cells co-expressing these proteins. The assay was configured in a 384-well-plate format for high-throughput screening with robust assay performance. To enable large-scale compound screening, we further miniaturized the assay into 1536-well ultrahigh-throughput screening (uHTS) format. A pilot screen demonstrated the utilization of the assay for uHTS. Our optimized TR-FRET uHTS assay provides an enabling platform for expanded screening campaigns to discover new classes of small-molecule inhibitors that target the SPIKE and TMPRSS2 protein-protein interaction.

SUBMITTER: Cicka D 

PROVIDER: S-EPMC10399917 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.

Cicka Danielle D   Niu Qiankun Q   Qui Min M   Qian Kun K   Miller Eric E   Fan Dacheng D   Mo Xiulei X   Ivanov Andrey A AA   Sarafianos Stefan G SG   Du Yuhong Y   Fu Haian H  

Journal of molecular cell biology 20230801 3


SARS-CoV-2, the coronavirus that causes the disease COVID-19, has claimed millions of lives over the past 2 years. This demands rapid development of effective therapeutic agents that target various phases of the viral replication cycle. The interaction between host transmembrane serine protease 2 (TMPRSS2) and viral SPIKE protein is an important initial step in SARS-CoV-2 infection, offering an opportunity for therapeutic development of viral entry inhibitors. Here, we report the development of  ...[more]

Similar Datasets

| S-EPMC10418891 | biostudies-literature
| S-EPMC8263067 | biostudies-literature
| EMPIAR-10947 | biostudies-other
| S-EPMC9346021 | biostudies-literature
| S-EPMC7811777 | biostudies-literature
| S-EPMC7523104 | biostudies-literature
| S-EPMC8646767 | biostudies-literature
| S-EPMC7535071 | biostudies-literature
| EMPIAR-11038 | biostudies-other
| EMPIAR-10891 | biostudies-other